Premium
Mind Medicine MindMed Inc (MNMD)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances inclu... Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies. Show more
Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...
- Voyage is the first-ever Phase 3 study of lysergide D-tartrate (LSD) with the primary endpoint measuring the change from baseline in the Hamilton Anxiety Rating Scale (HAM-A) score at week 12...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...
- Innovation Passport Designation Aims to Accelerate Time to Market and Facilitate Patient Access to Innovative Medicines - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.33 | 4.52054794521 | 7.3 | 7.6993 | 6.87 | 1132442 | 7.11557674 | CS |
| 4 | -0.67 | -8.07228915663 | 8.3 | 8.555 | 6.87 | 1091799 | 7.32656258 | CS |
| 12 | 2.12 | 38.4754990926 | 5.51 | 9.85 | 5.0329 | 1232481 | 7.32855957 | CS |
| 26 | 0.56 | 7.92079207921 | 7.07 | 9.85 | 5.0329 | 1059690 | 7.17334039 | CS |
| 52 | 3.98 | 109.04109589 | 3.65 | 12.22 | 3.49 | 1369374 | 7.88057827 | CS |
| 156 | -17.57 | -69.7222222222 | 25.2 | 25.65 | 2.12 | 2104441 | 11.63107348 | CS |
| 260 | -78.92 | -91.1842865396 | 86.55 | 86.55 | 2.12 | 2857995 | 26.13419858 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
